RA
Rosalind Advisors’s Cellectar Biosciences CLRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,671,550
| Closed | -$7.86M | – | 32 |
|
|
2024
Q3 | $7.86M | Buy |
3,671,550
+965,934
| +36% | +$2.07M | 5.03% | 9 |
|
|
2024
Q2 | $6.76M | Buy |
2,705,616
+2,084,138
| +335% | +$5.21M | 5.21% | 7 |
|
|
2024
Q1 | $2.47M | Sell |
621,478
-1,384,180
| -69% | -$5.51M | 2.31% | 19 |
|
|
2023
Q4 | $5.56M | Buy |
+2,005,658
| New | +$5.56M | 4.58% | 10 |
|